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ABSTRACT  Age-related macular degeneration (AMD) is one of the major diseases that 
cause severe visual impairment in developed countries and is related to dysfunction of the 
retinal pigment epithelium (RPE). Human induced pluripotent stem cells (hiPSCs) have been 
drawing attention as a valuable source of RPE for basic research on or treatment of AMD. Here 
we investigated whether RPE could be generated from hiPSCs in Kawasaki Medical School. 
We maintained hiPSCs retaining pluripotent markers after a series of regular culture steps 
involving passaging, freezing, and thawing. hiPSCs were then cultured in RPE differentiation 
medium, and pigmented colonies were manually isolated for further differentiation into RPE. 
Differentiated cells formed pigmented cells with a typical RPE cobblestone appearance, 
abundant apical microvilli, adherens junctions, and tight junctions. Furthermore, generated 
pigmented cells expressed typical RPE marker genes, exhibited a barrier function, and secreted 
growth factors in a polarity-dependent manner similar to native RPE. These results indicate that 
RPE derived from hiPSCs in our facility can be used for in vitro and in vivo research.
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INTRODUCTION
   Age-related macular degeneration (AMD)1) 
is caused by dysfunction of the retinal pigment 
epithelium (RPE), which plays an essential role in 
the maintenance of photoreceptors2) and a healthy 
ocular environment. The recent introduction of 
treatments such as laser therapy3), photodynamic 
therapy4), and anti-vascular endothelial growth 
factor therapy5) has resulted in significant overall 
maintenance or improvement of vision in AMD 
patients; however, a large number of AMD patients 
still have severe visual impairment with the limited 
effects of these therapies, such as non-responders, 
dry AMD, or advanced AMD. RPE transplantation 
with the aim of replacing pathological RPE with 
healthy RPE was introduced more than two decades 
ago, and RPE transplantation for AMD has been 
reported using allologous fetal RPE6) or autologous 
peripheral RPE7). In summary, the former exhibited 
complications associated with immune rejection, 
while the latter required invasive surgery to harvest 
peripheral RPE and place them in the submacular 
156 Kawasaki Medical Journal
area. Therefore, RPE derived from autologous 
human induced pluripotent stem cells (hiPSCs)8) 
emerged as an ideal alternative cell source to 
overcome these disadvantages.
   hiPSCs are typically reprogramed by transfecting 
stem cell-associated genes into adult somatic cells. 
Since hiPSCs share major characteristics with 
embryonic stem cells such as pluripotency, self-
renewal capacity, gene/protein expression, and 
epigenetic status, hiPSCs have been generated from 
various resources for research on and treatment of 
various diseases including retinitis pigmentosa9), 
Parkinson's disease10), and cardiovascular disease11). 
The hiPSC culture is completely different from 
other types of cell lines and requires specialized 
methods. Here we investigated whether a widely 
used hiPSC line could be cultured that retained 
pluripotency markers after a series of culture steps 
involving passaging, freezing, and thawing, and also 
tested if we could differentiate hiPSC-derived RPE 
(hiPSC-RPE) from them in our facility.
MATERIALS AND METHODS
Culture of hiPSCs and hiPSC-RPE
   The utilization of hiPSCs was approved by the 
Research committee of Kawasaki Medical School. 
The hiPS cell line, 253G1 produced from healthy 
human dermal fibroblast cells using 3 transcription 
factors (Oct3/4, Sox2, and Klf4) was purchased 
from RIKEN BioResource Center. These hiPSCs 
were seeded on Mitomycin C-treated mouse 
feeder cells (SNL cells) after frozen hiPSCs were 
immediately thawed by Primate ES Cell Medium 
(ReproCELL). hiPSCs were maintained in Primate 
ES Cell Medium supplemented with 5 ng/ml bFGF 
(Wako) and passaged by pipetting into small cell 
aggregates when hiPSC colonies became large. 
hiPSCs were put into freeze stock after three 
months culture using the vitrification method. To 
differentiate into RPE, hiPSCs were cultured on 
gelatin-coated dishes in the differentiation medium 
(GMEM; GMEM supplemented with 1 mM sodium 
pyruvate, 0.1 mM non-essential amino acids and 0.1 
mM 2-mercaptoethanol) and 20% KnockOut Serum 
Replacement (KSR) for 4 days, GMEM and 15% 
KSR for 6 days, and GMEM and 10% KSR for 20 
days. The Rho-associated kinase inhibitor Y-27632 
(10 µM, Wako), the ALK4 inhibitor SB431542 (5 
µM, Sigma), and the casein kinase I inhibitor CKI7 
(3 µM, Sigma) was added to the differentiation 
medium for 18 days. After the pigmented cells 
focally appeared, the differentiation medium was 
switched to SFRM [DMEM/F12 (7:3) supplemented 
with B27 (Invitrogen), 2 mM L-glutamine (Sigma)] 
for 7 days. Pigmented colonies were then transferred 
to laminin-coated dishes in SFRM supplemented 
with 10 ng/ml bFGF (Wako) and grown until 
confluence was reached.
Immunocytochemistry
   hiPSCs and hiPSC-RPE were fixed with 4% 
paraformaldehyde (PFA) and, after permeabilization 
with 0.3% TritonTM X-100 and blocking with 
blocking one (NACALAI), samples were incubated 
with the primary antibody overnight at 4℃ followed 
by secondary antibody reactions for 1 hr at room 
temperature. Antigens detected with primary 
antibodies (spices, company, and dilution) were; 
Oct3/4 (mouse, Santa Cruz, 1/500), Nanog (rabbit, 
ReproCELL, 1/500), SSEA-4 (mouse, Millipore, 
1/300), Tra-1-60 (mouse, Millipore, 1/300), Pax6 
(rabbit, Covance, 1/600), MITF (mouse, Abcam, 
1/1000), Bestrophin (mouse, Abcam, 1/500), RPE65 
(rabbit, 1/1000), and ZO-1 (rabbit, Zymed, 1/100). 
The bound primary antibodies were detected with 
secondary antibodies labeled with Alexa Fluor 546; 
goat anti-rabbit IgG (1/1000; Molecular Probes), or 
goat anti-mouse IgG (1/1000; Molecular Probes), 
and nuclei were stained with 4'6-diamindino-2-
phenylindole (DAPI) (Molecular Probes, 1 µg/ml). 
Specimens were imaged using a laser-scanning 
confocal microscope (FV1000-D, OLYMPUS).
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Transmission electron microscopy (TEM)
   hiPSC-RPE were fixed in 2.5% glutaraldehyde, 
postfixed with 1% osmium tetroxide, dehydrated 
with ascending concentrations of ethanol, and 
infiltrated by epoxy resin. Two days after drying 
under the hood, ultrathin sections, about 60 nm 
thick, were obtained with a microtome. hiPSC-
RPE were visualized with a transmission electron 
microscope (JEM-1400, JEOL).
Reverse transcription-polymerase chain reaction
   Total RNA was extracted from confluent hiPSCs 
(253G1) and hiPSC-RPE (253G1) using RNeasy 
Plus Mini Kit® (QIAGEN) according to the 
manufacturer's instructions. The RNA concentration 
and quality were assessed with a NanoDrop 1000 
spectrophotometer (NanoDrop Technoligies). The 
RNA was reversetranscribed using 20 µl reaction 
consisted of: 11 µl RNA (1,000 ng) in DNase RNase 
Free water (QIAGEN), 1 µl 50 µM Oligo(dT)20 
(Invitrogen), 1 µl 10 mM dNTP Mix (Invitrogen), 1 
µl Rnase OUT (20 U/µl; Invitrogen), SuperScriptTM 
III Reverse Transcriptase (4 µl 5×First-Standard 
Buffer, 1 µl 0.1M DTT, 1 µl SuperScript III 200 
U/µl; Invitrogen) and the cDNA synthesis was 
performed as follows: 15 min at 25℃, 60 min at 
50℃, and 15 min at 70℃. PCR reactions were 
performed using Ex Taq® DNA polymerase (Takara 
Bio). Thermal cycling conditions were performed as 
follows: one cycle at 94℃ for 120 sec; 30 cycles at 
94℃ for 30 sec, 57℃ for 30 sec, and 72℃ for 60 s; 
one cycle at 72℃ for 60 sec. Primer sequences used 
to amplify the three RPE-specific genes are listed in 
Table 1.
Measurement of transepithelial electrical resistance 
(TER)
   T E R  w a s  p e r f o r m e d  a c c o r d i n g  t o  t h e 
manufacturer's instructions of the electrical 
resistance system (Millicell®, Millipore) at 37℃. The 
TER value (Ωcm2) was calculated by subtracting 
the value of medium alone in the insert as a blank 
from the experimental value and multiplying it by 
the area of the insert membrane.
Enzyme linked immunosorbent assay (ELISA) for 
vascular endothelial growth factor (VEGF) and 
pigment epithelium-derived factor (PEDF)
   The culture medium from confluent hiPSC-RPE 
was collected 24 hr after the medium was changed. 
Secretion levels were measured by the human 
VEGF-ELISA Kit (eBioscience) for VEGF and 
human PEDF-ELISA Kit (BioVender) for PEDF, 
according to the manufacturers' instructions. 
RESULTS
Maintenance culture and characterization of hiPSCs
   To determine that we could stably culture hiPSCs 
in Kawasaki Medical School, we investigated if we 
could maintain hiPSCs that retained pluripotency 
markers after performing a series of culture steps 
involving passaging, freezing, and thawing. Firstly, 
provided hiPSCs (253G1) were thawed and seeded 
on Mitomycin C-treated SNL feeder cells (SNL). 
A medium change was made every day and hiPSC 
colonies are transferred onto new dishes with SNL 
feeder cells every 4 to 5 days. Three months after 
initiating the culture, hiPSCs were frozen and 
stocked in liquid nitrogen (the passage number was 
20). One week after being kept as a frozen stock, 
thawed hiPSCs were fed again for three months (the 
passage number was 38). The performed procedure 
Table 1.  Primer sequences used to amplify the four RPE-speciﬁc 
genes
primers Sequences
Bestrophin 1
Forward TAGAACCATCAGCGCCGTC
Reverse TGAGTGTAGTGTGTATGTTGG
RPE65
Forward TCCCCAATACAACTGCCACT
Reverse CCTTGGCATTCAGAATCAGG
MERTK
Forward TCCTTGGCCATCAGAAAAAG
Reverse CATTTGGGTGGCTGAAGTCT
GAPDH
Forward ACCACAGTCCATGCCATCAC
Reverse TCCACCACCCTGTTGCTGTA
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Fig. 1.　Maintenance culture and characterization of hiPSCs
(a) Culture steps involved in thawing, feeding, and freezing of hiPSCs (b) Phase image of a hiPSC colony with 
differentiated cells (arrow). Scale bar, 100 µm. (c) Phase image of hiPSCs. Scale bar, 100 µm (d-e) hiPSCs expressed the 
pluripotency markers OCT3/4, Nanog, SSEA4, and Tra-1-60. Scale bar, 200 µm.
was summarized in Figure 1a. When differentiated 
cells exhibiting a polygonal morphology appeared, 
we manually picked up the colonies including 
these differentiated cells (Fig. 1b). hiPSCs that 
went through the series of culture steps (Fig. 1c) 
retained the expression of pluripotency markers 
(OCT3/4 ,  Nanog, SSEA-4 ,  and Tra-1-60) in 
immunocytochemistry (Fig. 1d-g).
Generation of RPE from hiPSCs
   hiPSCs were then differentiated to RPE using a 
modified protocol established previously12). Three 
weeks after initiating differentiation, pigmented 
colonies presented a typical RPE cobblestone 
appearance (Fig. 2a). To purify these cells, we 
manually picked up, plated them onto a laminin 
coat dish, and cultured them until confluency 
was reached (Fig. 2b). To become fully mature 
cells, purified pigmented cells were continuously 
cultured at a confluent state (Fig. 2c, d). These 
pigmented cells had the structural characteristics 
of RPE including abundant apical microvilli, 
adherens junctions, and tight junctions under 
transmission electron microscopy (TEM) (Fig. 
2e-g). Furthermore, generated pigmented cells 
expressed typical RPE markers related to chloride 
channels (BEST1; Bestrophin 1)13), the retinoid 
cycle (RPE65)14,15), and phagocytosis (MERTK)16) in 
reverse transcriptase-polymerase chain reaction (RT-
PCR) (Fig. 3a) and eye field specification markers 
(PAX6 and MITF), BEST1, RPE65, and tight 
junction marker (ZO-1) in immunocytochemistry 
(Fig. 3b-f).
Functional assessment of hiPSC-RPE in vitro
   We investigated whether generated pigmented 
cells exhibited RPE functions typically observed 
in native RPE. Since RPE are known to contribute 
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Fig. 2.　Generation of RPE from hiPSCs
(a) Approximately 3 weeks after the initiation of differentiation, some cells formed pigmented colonies with a typical RPE 
cobblestone appearance (arrow). (b) Phase image of transferred pigmented cells cultured until confluency. Scale bar, 100 µm. 
(c) Purified pigmented cells became confluent. (d) Phase image of purified pigmented cells forming a typical RPE cobblestone 
appearance. Scale bar, 100 µm. (e) Transmission electron microscopy image of pigmented cells, (f) apical microvilli, and (g) 
adherens junctions and tight junctions.
Fig. 3.　Gene expression of RPE from hiPSCs
(a) Purified pigmented cells expressed typical RPE markers (BEST1, RPE65, and MERTK) 
in RT-PCR. (b-f) Purified pigmented cells derived from hiPSC expressed early (MITF, PAX6) 
and mature (BEST1, RPE65, ZO-1) RPE markers in immunocytochemistry. Scale bar, 50 µm.
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to the barrier function and secrete growth factors 
including vascular endothelial growth factor 
(VEGF) 17) and pigment epi thel ium-derived 
factor (PEDF)18), we evaluated the functional 
tight junction, or a barrier function by measuring 
transepithelial electrical resistance (TER)19), and 
measured the polarity-dependent concentration 
of VEGF and PEDF in the culture medium 
using ELISA. We seeded pigmented cells on the 
TranswellTM for these experiments. Four weeks after 
they became confluent, we measured the TER and 
concentration of PEDF and VEGF in the apical and 
basal media of the TranswellTM. The mean TER was 
410 Ω cm2 (n = 6) and concentration of VEGF was 
higher in the basal medium (5.9 ± 0.2 ng/well/24hr 
n = 3) than in the apical medium (1.2 ± 0.1 ng/
well/24hr n = 3), whereas that of PEDF was higher 
in the apical medium (600 ± 99 ng/well/24hr n = 3) 
than in the basal medium (380 ± 27 ng/well/24hr 
n = 3) (Fig. 4). All data are expressed as mean ± 
SEM (standard error of the mean), with P < 0.05 
being considered statistically significant. Statistical 
analyses were performed using StatMate4 (ATMS). 
Secretion of PEDF and VEGF was evaluated using 
paired t-tests.
DISCUSSION
   In this study, we demonstrated that we could 
successfully maintain hiPSCs and induce hiPSC-
RPE to be used for research in Kawasaki Medical 
School. 
   hiPSCs are currently a useful cell source for 
regenerative medicine, disease modeling, and drug 
testing, even though the hiPSC culture requires 
specialized methods. We had to demonstrate 
the pluripotency of hiPSCs and the function of 
generated differentiation cells. Therefore, we 
firstly confirmed that hiPSCs retained pluripotency 
after the series of regular culture steps involving 
passaging, freezing, and thawing. As shown Figure 
1, our hiPSCs retained the expression of OCT3/4, 
Nanog, SSEA-4, and Tra-1-60, which indicated that 
we could maintain these cells without losing their 
pluripotency.
   The limitation of existing clinical treatments 
for AMD has resulted in attention being given to 
replacing pathological RPE with healthy RPE. 
Research using hiPSC-RPE as an ideal cell source 
for transplantation is currently underway and 
RPE derived from embryonic stem cells is being 
examined in a clinical trial20). The differentiation 
methods of RPE from hiPSCs and generated hiPSC-
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Fig. 4.　Functional assessment of hiPSC-RPE in vitro
The concentration of VEGF was higher in the basal medium (5.9 ± 0.2 ng/well/24hr n = 3) than in the apical medium (1.2 ± 
0.1 ng/well/24hr n = 3), whereas that of PEDF was higher in the apical medium (600 ± 99 ng/well/24hr n = 3) than in the basal 
medium (380 ± 27 ng/well/24hr n = 3). All data are expressed as means ± SEM.  *P < 0.01,  **P < 0.05.
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RPE have displayed appropriate physiological 
properties in vitro and in vivo in previous 
reports21,22). As was shown in the results of the 
present study, our differentiated RPE also exhibited 
morphological and genetic properties consistent 
with typical RPE characteristics, which indicates 
that they can be used as tools for further RPE 
research.
   Another important observation in this study was 
that our hiPSC-RPE secreted VEGF and PEDF, 
as seen in Figure 4. Considering the roles of these 
factors in physiology and pathology, these results 
indicate that hiPSC-RPE transplantation could 
also be applied to various clinical purposes such 
as the protection of degenerating photoreceptors or 
regeneration of choroid vasculature. Therefore, we 
can utilize our hiPSC-RPE for clinically oriented 
research in vitro and in vivo in Kawasaki Medical 
School.
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